Cargando…
Short-course rapamycin treatment enables engraftment of immunogenic gene-engineered bone marrow under low-dose irradiation to permit long-term immunological tolerance
BACKGROUND: Application of genetically modified hematopoietic stem cells is increasingly mooted as a clinically relevant approach to protein replacement therapy, immune tolerance induction or conditions where both outcomes may be helpful. Hematopoietic stem and progenitor cell (HSPC)-mediated gene t...
Autores principales: | Bhatt, Kunal H., Rudraraju, Rajeev, Brooks, Jeremy F., Jung, Ji-Won, Galea, Ryan, Wells, James W., Steptoe, Raymond J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345164/ https://www.ncbi.nlm.nih.gov/pubmed/28279220 http://dx.doi.org/10.1186/s13287-017-0508-3 |
Ejemplares similares
-
Immunogenic, but Not Steady-State, Antigen Presentation Permits Regulatory T-Cells To Control CD8+ T-Cell Effector Differentiation by IL-2 Modulation
por: McNally, Alice, et al.
Publicado: (2014) -
Mesenchymal Stem Cells and Co-stimulation Blockade Enhance Bone Marrow Engraftment and Induce Immunological Tolerance
por: Rajeshkumar, B., et al.
Publicado: (2015) -
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
por: Meliani, Amine, et al.
Publicado: (2018) -
Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells
Publicado: (1992) -
Antioxidant Fusion Protein SOD1-Tat Increases the Engraftment Efficiency of Total Bone Marrow Cells in Irradiated Mice
por: Bei, Ting, et al.
Publicado: (2021)